Evercore ISI initiated coverage on shares of Express Scripts (NASDAQ:ESRX) in a report released on Thursday, January 4th, Marketbeat reports. The firm issued an in-line rating and a $78.00 price target on the stock.
A number of other equities analysts have also recently weighed in on the stock. Maxim Group increased their price objective on shares of Express Scripts from $78.00 to $87.00 and gave the stock a buy rating in a research report on Thursday, December 14th. Raymond James Financial reaffirmed an underperform rating on shares of Express Scripts in a research report on Monday, October 9th. Zacks Investment Research cut shares of Express Scripts from a buy rating to a sell rating in a research report on Tuesday, October 24th. Deutsche Bank started coverage on shares of Express Scripts in a research report on Monday, December 4th. They set a buy rating and a $75.00 price objective for the company. Finally, Royal Bank of Canada set a $66.00 price target on shares of Express Scripts and gave the company a hold rating in a research report on Wednesday, October 25th. Five analysts have rated the stock with a sell rating, ten have issued a hold rating, eight have issued a buy rating and two have given a strong buy rating to the stock. The stock presently has a consensus rating of Hold and an average price target of $77.09.
Express Scripts (NASDAQ:ESRX) traded down $0.26 during mid-day trading on Thursday, reaching $80.09. 5,054,100 shares of the company’s stock were exchanged, compared to its average volume of 4,064,975. The firm has a market cap of $45,360.00, a P/E ratio of 13.30, a price-to-earnings-growth ratio of 1.01 and a beta of 0.87. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. Express Scripts has a 12 month low of $55.80 and a 12 month high of $81.04.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $1.90. The business had revenue of $24.68 billion during the quarter, compared to the consensus estimate of $25.68 billion. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The business’s revenue was down 2.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.74 EPS. analysts anticipate that Express Scripts will post 7.04 earnings per share for the current year.
Express Scripts announced that its Board of Directors has authorized a share buyback plan on Monday, December 18th that permits the company to repurchase 45,000,000 outstanding shares. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its shares are undervalued.
In related news, VP Christine Houston sold 10,104 shares of Express Scripts stock in a transaction on Friday, December 15th. The shares were sold at an average price of $70.08, for a total transaction of $708,088.32. Following the sale, the vice president now directly owns 87,400 shares in the company, valued at approximately $6,124,992. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Phyllis S. Anderson sold 643 shares of Express Scripts stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total transaction of $40,103.91. The disclosure for this sale can be found here. Insiders sold a total of 14,195 shares of company stock worth $1,010,240 over the last 90 days. Company insiders own 0.68% of the company’s stock.
Large investors have recently made changes to their positions in the stock. Nordea Investment Management AB increased its stake in Express Scripts by 1.4% in the second quarter. Nordea Investment Management AB now owns 7,116,445 shares of the company’s stock valued at $454,314,000 after purchasing an additional 97,953 shares during the period. Van ECK Associates Corp boosted its holdings in shares of Express Scripts by 5.1% in the third quarter. Van ECK Associates Corp now owns 506,511 shares of the company’s stock valued at $32,072,000 after acquiring an additional 24,728 shares in the last quarter. Lazard Asset Management LLC boosted its holdings in shares of Express Scripts by 81.8% in the second quarter. Lazard Asset Management LLC now owns 112,666 shares of the company’s stock valued at $7,192,000 after acquiring an additional 50,707 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in shares of Express Scripts by 12.5% in the third quarter. Victory Capital Management Inc. now owns 35,421 shares of the company’s stock valued at $2,243,000 after acquiring an additional 3,940 shares in the last quarter. Finally, Legal & General Group Plc boosted its holdings in shares of Express Scripts by 1.7% in the second quarter. Legal & General Group Plc now owns 3,654,765 shares of the company’s stock valued at $233,323,000 after acquiring an additional 62,263 shares in the last quarter. Hedge funds and other institutional investors own 88.28% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://ledgergazette.com/2018/01/12/express-scripts-esrx-coverage-initiated-by-analysts-at-evercore-isi.html.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.